SUBSCRIBE
SUBSCRIBE
News   Drug Development

NC’s PPD, Inc. Clinical Trial Shows New Statin is Safe

July 31, 2007 | 
1 min read

WILMINGTON, NC--PPD Inc. (NASDAQ:PPDI) says it has completed a first-in-human study with its new statin for the treatment of high cholesterol. The compound was safe and well tolerated at all doses in this clinical trial.

Clinical research Phase I
MORE ON THIS TOPIC
A white pill being held by a hand wearing a blue surgical glove. Medicine or drugs isolated on a black background.
Obesity
Viking Touts Promising Phase I Weight Loss Data for Obesity Pill Candidate
November 4, 2024
 · 
2 min read
 · 
Tristan Manalac
Sep 17, 2020 Fremont / CA / USA - Novo Nordisk headquarters in Silicon Valley; Novo Nordisk A/S is a Danish multinational pharmaceutical company
GLP-1
Novo’s Wegovy Comparable to Madrigal’s Rezdiffra in Phase III MASH Trial: Analysts
November 1, 2024
 · 
3 min read
 · 
Heather McKenzie
LED Display - Airport flight status board
Layoffs
Compass Delays Pivotal Trial Readouts for Psilocybin in Depression, Lays Off 30% of Staff
October 31, 2024
 · 
2 min read
 · 
Heather McKenzie
Earnings
Sage Touts Q3 Zurzuvae Revenue Growth, Will Not Seek MDD Indication
October 30, 2024
 · 
2 min read
 · 
Heather McKenzie